174 related articles for article (PubMed ID: 7522538)
1. TP53 mutations are frequent in malignant NF1 tumors.
Legius E; Dierick H; Wu R; Hall BK; Marynen P; Cassiman JJ; Glover TW
Genes Chromosomes Cancer; 1994 Aug; 10(4):250-5. PubMed ID: 7522538
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
Menon AG; Anderson KM; Riccardi VM; Chung RY; Whaley JM; Yandell DW; Farmer GE; Freiman RN; Lee JK; Li FP
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5435-9. PubMed ID: 2142531
[TBL] [Abstract][Full Text] [Related]
4. A search for evidence of somatic mutations in the NF1 gene.
John AM; Ruggieri M; Ferner R; Upadhyaya M
J Med Genet; 2000 Jan; 37(1):44-9. PubMed ID: 10633134
[TBL] [Abstract][Full Text] [Related]
5. Congenital disseminated neurofibromatosis type 1: a clinical and molecular case report.
Stewart H; Bowker C; Edees S; Smalley S; Crocker M; Mechan D; Forrester N; Spurlock G; Upadhyaya M
Am J Med Genet A; 2008 Jun; 146A(11):1444-52. PubMed ID: 18438896
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1.
Estivill X; Lázaro C; Casals T; Ravella A
Hum Genet; 1991 Dec; 88(2):185-8. PubMed ID: 1757093
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of TP53 mutations in bladder carcinoma.
Williamson MP; Elder PA; Knowles MA
Genes Chromosomes Cancer; 1994 Feb; 9(2):108-18. PubMed ID: 7513540
[TBL] [Abstract][Full Text] [Related]
9. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis.
Glover TW; Stein CK; Legius E; Andersen LB; Brereton A; Johnson S
Genes Chromosomes Cancer; 1991 Jan; 3(1):62-70. PubMed ID: 1906341
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.
Park VM; Pivnick EK
J Med Genet; 1998 Oct; 35(10):813-20. PubMed ID: 9783703
[TBL] [Abstract][Full Text] [Related]
12. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.
Serra E; Ars E; Ravella A; Sánchez A; Puig S; Rosenbaum T; Estivill X; Lázaro C
Hum Genet; 2001 May; 108(5):416-29. PubMed ID: 11409870
[TBL] [Abstract][Full Text] [Related]
13. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.
Thomas L; Kluwe L; Chuzhanova N; Mautner V; Upadhyaya M
Neurogenetics; 2010 Oct; 11(4):391-400. PubMed ID: 20358387
[TBL] [Abstract][Full Text] [Related]
14. Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis.
Xu W; Mulligan LM; Ponder MA; Liu L; Smith BA; Mathew CG; Ponder BA
Genes Chromosomes Cancer; 1992 Jun; 4(4):337-42. PubMed ID: 1377942
[TBL] [Abstract][Full Text] [Related]
15. p53 mutation as the second event in juvenile chronic myelogenous leukemia in a patient with neurofibromatosis type 1.
Luria D; Avigad S; Cohen IJ; Stark B; Weitz R; Zaizov R
Cancer; 1997 Nov; 80(10):2013-8. PubMed ID: 9366306
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas.
Upadhyaya M; Spurlock G; Kluwe L; Chuzhanova N; Bennett E; Thomas N; Guha A; Mautner V
Neurogenetics; 2009 Jul; 10(3):251-63. PubMed ID: 19221814
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas.
Kluwe L; Friedrich RE; Mautner VF
Cancer Genet Cytogenet; 1999 Aug; 113(1):65-9. PubMed ID: 10459349
[TBL] [Abstract][Full Text] [Related]
18. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1.
Eisenbarth I; Beyer K; Krone W; Assum G
Am J Hum Genet; 2000 Feb; 66(2):393-401. PubMed ID: 10677298
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic analyses in neurofibromatosis type 1 patients with tumors.
Oguzkan S; Terzi YK; Cinbis M; Anlar B; Aysun S; Ayter S
Cancer Genet Cytogenet; 2006 Mar; 165(2):167-71. PubMed ID: 16527612
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.
Lothe RA; Fossli T; Danielsen HE; Stenwig AE; Nesland JM; Gallie B; Børresen AL
J Natl Cancer Inst; 1992 Jul; 84(14):1100-8. PubMed ID: 1619684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
